Trial intelligence / Profile preview

Carbetocin vs Oxytocin + TA for PPH Prevention

NCT03777878Unknown

Sponsor
Aswan University Hospital
Start
Jan 2019
Primary completion
Mar 2021
Modality
Peptides
Countries
1
01

Overview

Randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (3 arms), sponsored by Aswan University Hospital. Primary endpoint: Number of patients needing additional pharmacological uterotonic. Status: unknown.

02

Drugs

carbetocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT03777878.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03777878.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call